Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD) Peptide
HPGD
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN936298
Quick Overview for Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD) Peptide (ABIN936298)
Target
HPGD
(Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- DQQQLRDTFR KVVDHFGRLD ILVNNAGVNN EKNWEKTLQI NLVSVISGTY
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of HPGD antibody,
Alternative Names: HPGD control peptide, HPGD antibody Blocking Peptide, Anti-HPGD Blocking Peptide, hydroxyprostaglandin dehydrogenase 15-(NAD Blocking Peptide, Blocking Peptide, PGDH Blocking Peptide, PGDH1 Blocking Peptide, SDR36C1 Blocking Peptide -
Purification
- Immunoaffinity purification
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- HPGD (Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD))
-
Background
- This gene encodes a member of the short-chain nonmetalloenzyme alcohol dehydrogenase protein family. The encoded enzyme is responsible for the metabolism of prostaglandins, which function in a variety of physiologic and cellular processes such as inflammation. Mutations in this gene result in primary autosomal recessive hypertrophic osteoarthropathy and cranioosteoarthropathy. Multiple transcript variants encoding different isoforms have been found for this gene.
-
Molecular Weight
- 29 kDa
Target
-
You are here:
